RBTT-12. A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS WITH NEWLY, DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA: TRIAL IN PROGRESS

BACKGROUND: This study builds on the results of the University of Pennsylvania sponsored phase I study of a single peripheral infusion of chimeric antigen receptor (CAR) T cells targeting epidermal growth factor receptor variant III (EGFRvIII) in recurrent glioblastoma (GBM) (NCT02209376). A dose of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bagley, Stephen, Desai, Arati, Binder, Zev, Nasrallah, MacLean, Hwang, Wei-Ting, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, O’Rourke, Donald
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Randomized Brain Tumor Trials in Development
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846993/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.923
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados